|
시장보고서
상품코드
2151770
AI 단백질 설계 시장 규모, 점유율, 동향 분석 보고서 : 기술별, 단백질 유형별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)AI Protein Design Market Size, Share & Trends Analysis Report By Technology, By Protein Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
AI 단백질 설계 시장 요약
세계 AI 단백질 설계 시장 규모는 2025년 19억 달러로 평가되며, 2026년 25억 달러에서 2033년까지 209억 달러로 확대될 것으로 예상되며, 2026년부터 2033년까지의 연평균 성장률(CAGR)은 35.3%에 달할 것으로 전망됩니다.
북미가 시장을 주도하고 있으며, 2025년에는 매출 점유율의 44.8%를 차지했습니다. 시장 성장은 생성형 AI 및 단백질 기반 모델의 채택 확대, 보다 신속한 단백질 공학 및 바이오의약품 개발에 대한 수요 증가, 그리고 신약 개발, 치료용 단백질 개발, 효소 공학, 합성생물학 분야에서 AI 기반 단백질 설계의 응용 확대에 의해 주도되고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법 및 범위
제2장 요약
제3장 시장 : 변수, 동향, 범위
- 시장 계보 전망
- 시장 역학
- 업계 분석 도구
제4장 기술별 비즈니스 분석
- AI 단백질 설계 시장 : 기술별 동향 분석
- 생성형 AI
- 기계 학습
- 딥러닝
- 단백질 언어 모델
- 기타 AI 기술
제5장 단백질 유형별 비즈니스 분석
- AI 단백질 설계 시장 : 단백질 유형별 동향 분석
- 치료용 단백질
- 항체
- 효소
- 펩타이드
- 백신
- 기타 단백질
제6장 용도별 비즈니스 분석
- AI 단백질 설계 시장 : 용도별 동향 분석
- 신약 개발
- 단백질 공학
- de novo 단백질 설계
- 항체 설계
- 효소 설계
제7장 최종 용도별 비즈니스 분석
- AI 단백질 설계 시장 : 최종 용도별 동향 분석
- 제약·바이오기술 기업
- 학술 연구 기관
- CRO
제8장 지역별 비즈니스 분석
- AI 단백질 설계 시장 점유율 : 지역별, 2025년 및 2033년
- 북미
- 북미 AI 단백질 설계 시장, 2021-2033년
- 미국
- 캐나다
- 멕시코
- 유럽
- 유럽의 AI 단백질 설계 시장, 2021-2033년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 아시아태평양 AI 단백질 설계 시장, 2021-2033년
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
- 라틴아메리카
- 라틴아메리카 AI 단백질 설계 시장, 2021-2033년
- 브라질
- 아르헨티나
- 중동 및 아프리카
- MEA의 AI 단백질 설계 시장, 2021-2033년
- 남아프리카
- 사우디아라비아
- UAE
- 쿠웨이트
제9장 경쟁 현황
- 기업 분류
- 기업 점유율 및 포지셔닝 분석, 2025년
- 전략 매핑
- 기업 개요 목록
- EvolutionaryScale(acquired by Biohub)
- Cradle
- Profluent
- Arzeda Corporation
- Isomorphic Labs
- Schrodinger, Inc.
- Absci Corp.
- XtalPi Holdings
- Insilico Medicine
- Generate : Biomedicines
AI Protein Design Market Summary
The global AI protein design market size was valued at USD 1.9 billion in 2025 and is projected to grow from USD 2.5 billion in 2026 to USD 20.9 billion by 2033, at a CAGR of 35.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 44.8% in 2025. The market growth is driven by increasing adoption of generative AI and protein foundation models, growing demand for faster protein engineering and biologics discovery, and expanding applications of AI-based protein design in drug discovery, therapeutic protein development, enzyme engineering, and synthetic biology.
Global AI Protein Design Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country level and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global AI protein design market based on technology, protein type, application, end use, and region:
- Technology Outlook (Revenue, USD Billion, 2021 - 2033)
- Generative AI
- Machine Learning
- Deep Learning
- Protein Language Models
- Other AI Technologies
- Protein Type Outlook (Revenue, USD Billion, 2021 - 2033)
- Therapeutic Proteins
- Antibodies
- Enzymes
- Peptides
- Vaccines
- Other Proteins
- Application Outlook (Revenue, USD Billion, 2021 - 2033)
- Drug Discovery
- Protein Engineering
- De Novo Protein Design
- Antibody Design
- Enzyme Design
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- CROs
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Technology Segment
- 1.1.1.2. Protein Type Segment
- 1.1.1.3. Application Segment
- 1.1.1.4. End Use Segment
- 1.1.1. Segment Definitions
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. List of Secondary Sources
- 1.9.3. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing Adoption of Generative AI for De Novo Protein Design
- 3.2.1.2. Growing Adoption of AI-Driven Protein Structure Prediction and Optimization
- 3.2.1.3. Increasing Use of AI-Enabled Protein Design in Therapeutic and Enzyme Development
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Technical Limitations and Experimental Validation Challenges
- 3.2.2.2. High Computational Costs and Infrastructure Requirements
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Economic landscape
- 3.3.2.5. Legal landscape
- 3.3.2.6. Environmental landscape
- 3.3.1. Porter's Five Forces Analysis
Chapter 4. Technology Business Analysis
- 4.1. Segment Dashboard
- 4.2. AI Protein Design Market: Technology Movement Analysis
- 4.3. Generative AI
- 4.3.1. Generative AI Market, 2021 - 2033 (USD Billion)
- 4.4. Machine Learning
- 4.4.1. Machine Learning Market, 2021 - 2033 (USD Billion)
- 4.5. Deep Learning
- 4.5.1. Deep Learning Market, 2021 - 2033 (USD Billion)
- 4.6. Protein Language Models
- 4.6.1. Protein Language Models Market, 2021 - 2033 (USD Billion)
- 4.7. Other AI Technologies
- 4.7.1. Other AI Technologies Market, 2021 - 2033 (USD Billion)
Chapter 5. Protein Type Business Analysis
- 5.1. Segment Dashboard
- 5.2. AI Protein Design Market: Protein Type Movement Analysis
- 5.3. Therapeutic Proteins
- 5.3.1. Therapeutic Proteins Market, 2021 - 2033 (USD Billion)
- 5.4. Antibodies
- 5.4.1. Antibodies Market, 2021 - 2033 (USD Billion)
- 5.5. Enzymes
- 5.5.1. Enzymes Market, 2021 - 2033 (USD Billion)
- 5.6. Peptides
- 5.6.1. Peptides Market, 2021 - 2033 (USD Billion)
- 5.7. Vaccines
- 5.7.1. Vaccines Market, 2021 - 2033 (USD Billion)
- 5.8. Other Proteins
- 5.8.1. Other Proteins Market, 2021 - 2033 (USD Billion)
Chapter 6. Application Business Analysis
- 6.1. Segment Dashboard
- 6.2. AI Protein Design Market: Application Movement Analysis
- 6.3. Drug Discovery
- 6.3.1. Drug Discovery Market, 2021 - 2033 (USD Billion)
- 6.4. Protein Engineering
- 6.4.1. Protein Engineering Market, 2021 - 2033 (USD Billion)
- 6.5. De Novo Protein Design
- 6.5.1. De Novo Protein Design Market, 2021 - 2033 (USD Billion)
- 6.6. Antibody Design
- 6.6.1. Antibody Design Market, 2021 - 2033 (USD Billion)
- 6.7. Enzyme Design
- 6.7.1. Enzyme Design Market, 2021 - 2033 (USD Billion)
Chapter 7. End Use Business Analysis
- 7.1. Segment Dashboard
- 7.2. AI Protein Design Market: End Use Movement Analysis
- 7.3. Pharmaceutical & Biotechnology Companies
- 7.3.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Billion)
- 7.4. Academic & Research Institutes
- 7.4.1. Academic & Research Institutes Market, 2021 - 2033 (USD Billion)
- 7.5. CROs
- 7.5.1. CROs Market, 2021 - 2033 (USD Billion)
Chapter 8. Regional Business Analysis
- 8.1. AI Protein Design Market Share By Region, 2025 & 2033
- 8.2. North America
- 8.2.1. North America AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.2.2. U.S.
- 8.2.2.1. Key Country Dynamics
- 8.2.2.2. Competitive Scenario
- 8.2.2.3. Regulatory Framework
- 8.2.2.4. U.S. AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.2.3. Canada
- 8.2.3.1. Key Country Dynamics
- 8.2.3.2. Competitive Scenario
- 8.2.3.3. Regulatory Framework
- 8.2.3.4. Canada AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.2.4. Mexico
- 8.2.4.1. Key Country Dynamics
- 8.2.4.2. Competitive Scenario
- 8.2.4.3. Regulatory Framework
- 8.2.4.4. Mexico AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.3.2. UK
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. UK AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.3.3. Germany
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Germany AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.3.4. France
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. France AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.3.5. Italy
- 8.3.5.1. Key Country Dynamics
- 8.3.5.2. Competitive Scenario
- 8.3.5.3. Regulatory Framework
- 8.3.5.4. Italy AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.3.6. Spain
- 8.3.6.1. Key Country Dynamics
- 8.3.6.2. Competitive Scenario
- 8.3.6.3. Regulatory Framework
- 8.3.6.4. Spain AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.3.7. Denmark
- 8.3.7.1. Key Country Dynamics
- 8.3.7.2. Competitive Scenario
- 8.3.7.3. Regulatory Framework
- 8.3.7.4. Denmark AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.3.8. Sweden
- 8.3.8.1. Key Country Dynamics
- 8.3.8.2. Competitive Scenario
- 8.3.8.3. Regulatory Framework
- 8.3.8.4. Sweden AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.3.9. Norway
- 8.3.9.1. Key Country Dynamics
- 8.3.9.2. Competitive Scenario
- 8.3.9.3. Regulatory Framework
- 8.3.9.4. Norway AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.4.2. Japan
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Japan AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.4.3. China
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. China AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.4.4. India
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. India AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.4.5. Australia
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Australia AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.4.6. Thailand
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Thailand AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.4.7. South Korea
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. South Korea AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.5.2. Brazil
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Brazil AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.5.3. Argentina
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Argentina AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.6. MEA
- 8.6.1. MEA AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.6.2. South Africa
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. South Africa AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.6.3. Saudi Arabia
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Saudi Arabia AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.6.4. UAE
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. UAE AI Protein Design Market, 2021 - 2033 (USD Billion)
- 8.6.5. Kuwait
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Kuwait AI Protein Design Market, 2021 - 2033 (USD Billion)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Company Market Share/ Position Analysis, 2025
- 9.3. Strategy Mapping
- 9.4. Company Profiles/Listing
- 9.4.1. EvolutionaryScale (acquired by Biohub)
- 9.4.1.1. Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Type Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Cradle
- 9.4.2.1. Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Type Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. Profluent
- 9.4.3.1. Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Type Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Arzeda Corporation
- 9.4.4.1. Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Type Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Isomorphic Labs
- 9.4.5.1. Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Type Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. Schrodinger, Inc.
- 9.4.6.1. Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Type Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. Absci Corp.
- 9.4.7.1. Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Type Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. XtalPi Holdings
- 9.4.8.1. Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Type Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Insilico Medicine
- 9.4.9.1. Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Type Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. Generate:Biomedicines
- 9.4.10.1. Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Type Benchmarking
- 9.4.10.4. Strategic Initiatives
- 9.4.1. EvolutionaryScale (acquired by Biohub)
